Non-bacterial thrombotic endocarditis surgery: Difference between revisions
Jump to navigation
Jump to search
Homa Najafi (talk | contribs) No edit summary |
Aisha Adigun (talk | contribs) |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Non-bacterial thrombotic endocarditis}} | {{Non-bacterial thrombotic endocarditis}} | ||
{{CMG}}; {{AE}}{{ | {{CMG}}; {{AE}}{{Aisha}} | ||
==Overview== | ==Overview== | ||
Surgery is not the first-line treatment option for patients with non-bacterial thrombotic endocarditis and is usually reserved for patients with either heart failure, acute valve rupture, or recurrence of thromboembolism despite adequate anticoagulation. It is important to weigh the risks associated with the patient's underlying condition with the benefits of surgery. | |||
Surgery is not the first-line treatment option for patients with | |||
==Indications== | ==Indications== | ||
*Surgery is not the first-line treatment option for patients with non-bacterial thrombotic endocarditis<ref name="pmid8875919">{{cite journal |vauthors=Roldan CA, Shively BK, Crawford MH |title=An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus |journal=N. Engl. J. Med. |volume=335 |issue=19 |pages=1424–30 |date=November 1996 |pmid=8875919 |doi=10.1056/NEJM199611073351903 |url=}}</ref>. | |||
*Surgery to replace or repair the valve is usually reserved for patients with either heart failure, acute valve rupture, or recurrence of thromboembolism despite adequate anticoagulation<ref name="pmid15726628">{{cite journal |vauthors=Rabinstein AA, Giovanelli C, Romano JG, Koch S, Forteza AM, Ricci M |title=Surgical treatment of nonbacterial thrombotic endocarditis presenting with stroke |journal=J. Neurol. |volume=252 |issue=3 |pages=352–5 |date=March 2005 |pmid=15726268 |doi=10.1007/s00415-005-0660-z |url=}}</ref>. | |||
*Mitral valve replacement surgery has an operative mortality of as high as 25% in patients with Libman-Sacks endocarditis. | |||
*Surgery is not the first-line treatment option for patients with | *The main reason for surgery in NBTE is the prevention of recurrent thromboembolism. | ||
*As opposed to infective endocarditis where the entire valve may need to be removed, valve preservation is possible in NBTE<ref name="urlNon-bacterial Thrombotic Endocarditis | IntechOpen">{{cite web |url=https://www.intechopen.com/books/infective-endocarditis/non-bacterial-thrombotic-endocarditis |title=Non-bacterial Thrombotic Endocarditis | IntechOpen |format= |work= |accessdate=}}</ref>. | |||
*When considering surgery as an option, it is important to weigh the risks associated with the patient's underlying condition with the benefits of surgery<ref name="pmid16965557">{{cite journal |vauthors=Aryana A, Esterbrooks DJ, Morris PC |title=Nonbacterial thrombotic endocarditis with recurrent embolic events as manifestation of ovarian neoplasm |journal=J Gen Intern Med |volume=21 |issue=12 |pages=C12–5 |date=December 2006 |pmid=16965557 |pmc=1924740 |doi=10.1111/j.1525-1497.2006.00614.x |url=}}</ref>. | |||
== | |||
* | |||
* | |||
== | |||
==References== | ==References== | ||
Latest revision as of 21:09, 22 August 2020
|
non-bacterial thrombotic endocarditis |
|
Differentiating non-bacterial thrombotic endocarditis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Non-bacterial thrombotic endocarditis surgery On the Web |
|
American Roentgen Ray Society Images of Non-bacterial thrombotic endocarditis surgery |
|
Risk calculators and risk factors for Non-bacterial thrombotic endocarditis surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aisha Adigun, B.Sc., M.D.[2]
Overview
Surgery is not the first-line treatment option for patients with non-bacterial thrombotic endocarditis and is usually reserved for patients with either heart failure, acute valve rupture, or recurrence of thromboembolism despite adequate anticoagulation. It is important to weigh the risks associated with the patient's underlying condition with the benefits of surgery.
Indications
- Surgery is not the first-line treatment option for patients with non-bacterial thrombotic endocarditis[1].
- Surgery to replace or repair the valve is usually reserved for patients with either heart failure, acute valve rupture, or recurrence of thromboembolism despite adequate anticoagulation[2].
- Mitral valve replacement surgery has an operative mortality of as high as 25% in patients with Libman-Sacks endocarditis.
- The main reason for surgery in NBTE is the prevention of recurrent thromboembolism.
- As opposed to infective endocarditis where the entire valve may need to be removed, valve preservation is possible in NBTE[3].
- When considering surgery as an option, it is important to weigh the risks associated with the patient's underlying condition with the benefits of surgery[4].
References
- ↑ Roldan CA, Shively BK, Crawford MH (November 1996). "An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus". N. Engl. J. Med. 335 (19): 1424–30. doi:10.1056/NEJM199611073351903. PMID 8875919.
- ↑ Rabinstein AA, Giovanelli C, Romano JG, Koch S, Forteza AM, Ricci M (March 2005). "Surgical treatment of nonbacterial thrombotic endocarditis presenting with stroke". J. Neurol. 252 (3): 352–5. doi:10.1007/s00415-005-0660-z. PMID 15726268.
- ↑ "Non-bacterial Thrombotic Endocarditis | IntechOpen".
- ↑ Aryana A, Esterbrooks DJ, Morris PC (December 2006). "Nonbacterial thrombotic endocarditis with recurrent embolic events as manifestation of ovarian neoplasm". J Gen Intern Med. 21 (12): C12–5. doi:10.1111/j.1525-1497.2006.00614.x. PMC 1924740. PMID 16965557.